Cryo-Cell International (STU:ZCY) Cyclically Adjusted Book per Share: €-1.06 (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:ZCY Cryo-Cell International Inc STU:ZCY
57 GF Score
Price €2.76
GF Value €4.36
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cryo-Cell International Cyclically Adjusted Book per Share?

Cryo-Cell International STU:ZCY -8.61% 57 Cyclically Adjusted Book per Share is €-1.06 as of May. 2026. GuruFocus rates STU:ZCY with a GF Score™ of 57/100 and a GF Value™ of €4.36 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Cryo-Cell International's adjusted book value per share for the three months ended in May. 2026 was €-1.885. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €-1.06 for the trailing ten years ended in May. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -3.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -1.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -5.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Cryo-Cell International was 1.30% per year. The lowest was -72.30% per year. And the median was -19.50% per year.

As of today (2026-07-19), Cryo-Cell International's current stock price is €2.76. Cryo-Cell International's Cyclically Adjusted Book per Share for the quarter that ended in May. 2026 was €-1.06. Cryo-Cell International's Cyclically Adjusted PB Ratio of today is .


Cryo-Cell International  (STU:ZCY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Cryo-Cell International Cyclically Adjusted Book per Share Related Terms


Cryo-Cell International Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International Cyclically Adjusted Book per Share Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.02 -0.97

Cryo-Cell International Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.94 -0.98 -0.97 -1.00 -1.06

STU:ZCY vs CCM, CDIX, EHSI: Cyclically Adjusted Book per Share Comparison

For the Medical Care Facilities subindustry, Cryo-Cell International's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International Cyclically Adjusted PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's Cyclically Adjusted PB Ratio falls into.


STU:ZCY
57GF Score
Cryo-Cell International Inc STU:ZCY
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cryo-Cell International's adjusted Book Value per Share data for the three months ended in May. 2026 was:

Adj_Book= Book Value per Share /CPI of May. 2026 (Change)*Current CPI (May. 2026)
=-1.885/335.1230*335.1230
=-1.885

Current CPI (May. 2026) = 335.1230.

Cryo-Cell International Quarterly Data

Book Value per Share CPI Adj_Book
201608 -2.224 240.849 -3.095
201611 -2.104 241.353 -2.921
201702 -1.962 243.603 -2.699
201705 -1.820 244.733 -2.492
201708 -1.599 245.519 -2.183
201711 -1.500 246.669 -2.038
201802 -1.637 248.991 -2.203
201805 -1.640 251.588 -2.185
201808 -1.093 252.146 -1.453
201811 -1.005 252.038 -1.336
201902 -0.930 252.776 -1.233
201905 -0.927 256.092 -1.213
201908 -0.802 256.558 -1.048
201911 -0.838 257.208 -1.092
202002 -0.729 258.678 -0.944
202005 -0.605 256.394 -0.791
202008 -0.452 259.918 -0.583
202011 -0.299 260.229 -0.385
202102 -0.185 263.014 -0.236
202105 0.390 269.195 0.486
202108 0.478 273.567 0.586
202111 0.428 277.948 0.516
202202 0.441 283.716 0.521
202205 0.496 292.296 0.569
202208 -0.276 296.171 -0.312
202211 -0.176 297.711 -0.198
202302 -0.076 300.840 -0.085
202305 -0.095 304.127 -0.105
202308 -0.002 307.026 -0.002
202311 -1.230 307.051 -1.342
202402 -1.161 310.326 -1.254
202405 -1.232 314.069 -1.315
202408 -1.075 314.796 -1.144
202411 -1.540 315.493 -1.636
202502 -1.741 319.082 -1.829
202505 -1.712 321.465 -1.785
202508 -1.582 323.976 -1.636
202511 -1.998 324.122 -2.066
202602 -1.932 326.785 -1.981
202605 -1.885 335.123 -1.885

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €-1.06 mean?
Cryo-Cell International (STU:ZCY) has a Cyclically Adjusted Book per Share of €-1.06 as of May. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cryo-Cell International and its competitors.
Is Cryo-Cell International's Cyclically Adjusted Book per Share too high?
Cryo-Cell International's current Cyclically Adjusted Book per Share is €-1.06. Overall, Cryo-Cell International has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryo-Cell International's Cyclically Adjusted Book per Share compare to CCM and CDIX?
Cryo-Cell International's Cyclically Adjusted Book per Share of €-1.06 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Book per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cryo-Cell International and its competitors. Cryo-Cell International's current Cyclically Adjusted Book per Share is €-1.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryo-Cell International stock overvalued right now?
Based on GuruFocus' analysis, Cryo-Cell International (STU:ZCY) is currently considered Possible Value Trap. The stock's GF Value™ is €4.36, compared to a current price of €2.76 — trading 36.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is €-1.06. Cryo-Cell International's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Cryo-Cell International (STU:ZCY), the current Cyclically Adjusted Book per Share is €-1.06 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cryo-Cell International (STU:ZCY) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of €2.76 is trading 36.7% below its estimated GF Value™ of €4.36. GuruFocus considers Cryo-Cell International to be Possible Value Trap.

Key valuation signals for STU:ZCY:

  • Cyclically Adjusted Book per Share: €-1.06
  • GF Value™: €4.36 vs. price of €2.76 (36.7% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the STU:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cryo-Cell International Business Description

Other Exchanges CCEL:USAZCY:Germany
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
57GF Score

Get the complete analysis for STU:ZCY

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.76
Price
€4.36
GF Value